RxDoctor Payments DataLook up a doctor →

Nicholas Austin, PA

Physician Assistant · Longview, WANPI 1063069383

Payments from drug & device makers

$7,561in general payments, 2019–2025

Across 412 payments — averaging $18.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$654
  • GSK$577
  • Novartis$541
  • AbbVie$500
  • Novo Nordisk$476
  • Johnson & Johnson$393
  • plus $4K from 52 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca34$654
GSK35$577
Novartis22$541
AbbVie26$500
Novo Nordisk27$476
Johnson & Johnson35$393
Lilly USA, LLC21$379
Bayer19$357
Amgen18$349
Pfizer15$320
E.r. Squibb & Sons, L.L.C.15$247
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC12$219
Xeris Pharmaceuticals, Inc.6$214
Boehringer Ingelheim10$212
Amarin Pharma, Inc.13$205
Esperion Therapeutics, Inc.11$171
Otsuka America Pharmaceutical, Inc.8$153
Corcept Therapeutics4$94
Actelion Pharmaceuticals US, Inc.4$92
Lundbeck LLC4$83
Sanofi-aventis U.S. LLC4$80
Daiichi Sankyo Inc.4$76
Grifols USA, LLC4$71
Sunovion Pharmaceuticals Inc.4$65
Abbott2$59
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$58
Electromed, Inc.4$57
Takeda Pharmaceuticals U.S.A., Inc.3$57
Merck3$49
Phathom Pharmaceuticals, Inc.2$49
Mylan Specialty L.p.3$48
Edwards Lifesciences2$45
Exact Sciences2$43
Arbor Pharmaceuticals, Inc.3$42
Boston Scientific2$41
Astellas Pharma US Inc2$37
Vertex2$37
Azurity Pharmaceuticals, Inc.2$32
Regeneron Healthcare Solutions, Inc.2$31
Biohaven Pharmaceuticals, Inc.2$31
Corium, LLC1$25
Echosens North America, Inc.1$24
Sumitomo Pharma America, Inc.1$23
Amneal Pharmaceuticals LLC1$23
Radius Health, Inc.1$21
Seqirus USA Inc1$21
Eisai Inc.1$19
Biohaven Pharmaceutical Holding Company Ltd.1$18
Idorsia Pharmaceuticals US Inc1$17
Philips North America LLC1$15
Inspire Medical Systems, Inc.1$15
Aimmune Therapeutics, Inc.1$15
Kowa Pharmaceuticals America, Inc.1$14
Lexicon Pharmaceuticals, Inc.1$14
Bardy Diagnostics, Inc.1$14
Nevro Corp.1$14
Paratek Pharmaceuticals, Inc.1$14
CMP Pharma, Inc.1$12

How this compares

$7,561 in reported general payments places this provider in the 95th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington →

Medicare billing

Part B allowed, 2024
$13,598
Medicare patients
86
Services billed
441

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Longview

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →